Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.08 is 21% below its 5-year average of 2.63, around the middle of its 5-year range (0.67–4.91).
As of the fiscal period ended Tuesday, June 30, 2026. 33.09% below its 12-month average of 3.11.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.08.
QUICK RATIO (ACID-TEST)
2.08
QUICK RATIO (ACID-TEST) AVG TTM
3.11
QUICK RATIO (ACID-TEST) AVG 3Y
2.49
QUICK RATIO (ACID-TEST) AVG 5Y
2.63
QUICK RATIO (ACID-TEST) AVG 10Y
2.82
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-33.09%
CURRENT VS 3Y AVG
-16.33%
CURRENT VS 5Y AVG
-20.90%
CURRENT VS 10Y AVG
-26.28%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 613 covered companies
CURRENT VS SECTOR MEDIAN
-30.39%
vs the sector median at left
Aptevo Therapeutics Inc.
Market Cap
$4.00M
Quick Ratio (Acid-Test)
2.08
TTM Avg
3.11
3Y Avg
2.49
5Y Avg
2.63
Market Cap
$4.08M
Quick Ratio (Acid-Test)
2.01
TTM Avg
0.91
3Y Avg
1.26
5Y Avg
1.78
Market Cap
$4.28M
Quick Ratio (Acid-Test)
1.95
TTM Avg
2.83
3Y Avg
3.75
5Y Avg
3.40
Market Cap
$4.43M
Quick Ratio (Acid-Test)
1.35
TTM Avg
3.30
3Y Avg
6.18
5Y Avg
6.77
Market Cap
$3.49M
Quick Ratio (Acid-Test)
1.97
TTM Avg
1.45
3Y Avg
2.21
5Y Avg
4.94
Market Cap
$3.49M
Quick Ratio (Acid-Test)
1.10
TTM Avg
5.81
3Y Avg
5.76
5Y Avg
3.90
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | $4.00M | 2.08 | 3.11 | 2.49 | 2.63 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.08M | 2.01 | 0.91 | 1.26 | 1.78 |
| GRI Bio, Inc. (GRI)vs › | $4.18M | 10.30 | 3.34 | 1.98 | 1.38 |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.28M | 1.95 | 2.83 | 3.75 | 3.40 |
| Eocene Ltd. (EOCN)vs › | $3.57M | N/A | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.43M | 1.35 | 3.30 | 6.18 | 6.77 |
| Evogene Ltd. (EVGN)vs › | $3.52M | 3.54 | 2.77 | 4.28 | 5.12 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 1.97 | 1.45 | 2.21 | 4.94 |
| Nexalin Technology, Inc. (NXL)vs › | $3.49M | 1.10 | 5.81 | 5.76 | 3.90 |
| Moolec Science S.A. (MLEC)vs › | $3.46M | 0.08 | 0.52 | 0.43 | 0.47 |
Quick Ratio
2.08
Excludes inventory
Current Ratio
2.08
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.08 |
| 2026-03-31 | 3.36 |
| 2025-12-31 | 3.82 |
| 2025-09-30 | 4.03 |
| 2025-06-30 | 2.27 |
| 2025-03-31 | 0.67 |
| 2024-12-31 | 1.72 |
| 2024-09-30 | 1.70 |
| 2024-06-30 | 1.77 |
| 2024-03-31 | 1.92 |
| 2023-12-31 | 2.64 |
| 2023-09-30 | 3.09 |
| 2023-06-30 | 3.28 |
| 2023-03-31 | 4.91 |
| 2022-12-31 | 3.15 |
| 2022-09-30 | 3.16 |
| 2022-06-30 | 4.48 |
| 2022-03-31 | 1.75 |
| 2021-12-31 | 1.51 |
| 2021-09-30 | 1.82 |
| 2021-06-30 | 2.13 |
| 2021-03-31 | 2.14 |
| 2020-12-31 | 3.25 |
| 2020-09-30 | 4.13 |
| 2020-06-30 | 1.50 |
| 2020-03-31 | 2.12 |
| 2019-12-31 | 0.62 |
| 2019-09-30 | 0.79 |
| 2019-06-30 | 2.21 |
| 2019-03-31 | 2.91 |
| 2018-12-31 | 2.66 |
| 2018-09-30 | 3.65 |
| 2018-06-30 | 3.50 |
| 2018-03-31 | 4.39 |
| 2017-12-31 | 5.08 |
| 2017-09-30 | 7.67 |
| 2017-06-30 | 4.98 |
| 2017-03-31 | 4.80 |
| 2016-12-31 | 3.31 |
| 2016-09-30 | 4.45 |
| 2016-06-30 | 1.16 |
| 2016-03-31 | 2.96 |
| 2015-12-31 | 0.74 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
